This report describes and explains the liquid biopsy for cancer diagnostics market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report ...

As of December 2024, Guardant held $840 million of cash and marketable securities. However, it burned through approximately $390 million in 2022, $345 million in 2023, and $275 million in 2024.

Candel Therapeutics' lead candidate CAN-2409 shows promising results in several indications. Find out why I rate CADL stock ...

The patients with IPF had disease proven clinically or by biopsy. There were no restrictions ... 12 individuals with advanced stage non-small cell lung cancer and 17 healthy controls provided breath ...

Doctors at Lakeland Regional Health are now equipped with cutting-edge robotic technology to better detect lung cancer.

A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.

Overview of the Breast Cancer Diagnostics MarketThe Breast Cancer Diagnostics Market plays a pivotal role in the healthcare ...

Respiratory diseases are a challenging problem to treat. Inhalable medicines are a promising solution that depends on the ...

6, 2025 — Despite new medication, cystic fibrosis often leads to permanent lung damage ... Oct. 11, 2024 — Clinician-scientists analyzed samples from patients' airways and blood, finding ...

Lakeland Regional Health is using a new cutting-edge technology called the ION robot to help cure lung cancer. The robot allows doctors to reach the lesions at the edge of the lung and collect tissue ...